| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Streamex Corp. | CFO | Common Stock | 295K | $1.4M | $4.74 | Nov 18, 2025 | Direct |
| Alaunos Therapeutics, Inc. | Vice President of Finance | Common Stock | 10.8K | $22.6K | $2.10 | Aug 18, 2025 | Direct |
| Muscle Maker, Inc. | Chief Accounting Officer | Stock Options | 25K | May 2, 2022 | Direct | ||
| Alaunos Therapeutics, Inc. | Vice President of Finance | Employee Stock Option (right to buy) | 4K | Aug 18, 2025 | Direct | ||
| Muscle Maker, Inc. | Chief Accounting Officer | Common Stock | 0 | $0.40 | Feb 15, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| STEX | Streamex Corp. | Nov 18, 2025 | 1 | $0 | 4 | Nov 21, 2025 | CFO |
| TCRT | Alaunos Therapeutics, Inc. | Aug 18, 2025 | 2 | $0 | 4 | Aug 20, 2025 | Vice President of Finance |
| BSGM | BioSig Technologies, Inc. | May 29, 2025 | 1 | $0 | 4 | Jun 2, 2025 | Interim CFO |
| BSGM | BioSig Technologies, Inc. | Apr 24, 2025 | 1 | $0 | 4 | Apr 29, 2025 | Interim CFO |
| TCRT | Alaunos Therapeutics, Inc. | Mar 29, 2025 | 1 | $0 | 4 | Apr 1, 2025 | VP, Finance |
| BSGM | BioSig Technologies, Inc. | Jan 13, 2025 | 0 | $0 | 3 | Jan 15, 2025 | Interim CFO |
| TCRT | Alaunos Therapeutics, Inc. | Aug 14, 2024 | 1 | $0 | 4 | Aug 16, 2024 | VP, Finance |
| BSGM | BioSig Technologies, Inc. | Jun 10, 2024 | 0 | $0 | 3 | Jul 5, 2024 | Chief Financial Officer |
| TCRT | Alaunos Therapeutics, Inc. | Feb 22, 2024 | 0 | $0 | 3 | Feb 28, 2024 | Vice President, Finance |
| SDOT | Muscle Maker, Inc. | May 2, 2022 | 1 | $0 | 4 | May 4, 2022 | Chief Accounting Officer |
| SDOT | Muscle Maker, Inc. | Feb 15, 2022 | 1 | -$11.2K | 4 | Feb 18, 2022 | Chief Accounting Officer |
| HTCR | HeartCore Enterprises, Inc. | Feb 9, 2022 | 0 | $0 | 3 | Feb 9, 2022 | Director |